Document Detail

Effectiveness of atenolol in the treatment of hypertension during pregnancy.
MedLine Citation:
PMID:  1735566     Owner:  NLM     Status:  MEDLINE    
This study assessed the effectiveness of atenolol in the treatment of moderate and severe hypertension during pregnancy. Seventy patients (mean age, 30.3 +/- 6.0 years), 35.7% primiparous, were included. Three groups were formed according to Davey and MacGillivray's classification: 1) chronic hypertension without proteinuria (12 patients), 2) gestational hypertension without proteinuria (52 patients), and 3) preeclampsia (six patients). Treatment with atenolol was started when blood pressure was 150/100 mm Hg or higher after 48 hours' rest. The treatment lasted at least 1 week; follow-up was every 2 weeks up to week 36, and from then on, weekly up to delivery. If blood pressure exceeded 160/110 mm Hg and the fetus was not yet mature, a second drug was added. A significant decrease in blood pressure was observed in the three groups (group 1: 155.8 +/- 15.0/100.8 +/- 7.6 versus 135.0 +/- 12.9/85.0 +/- 6.7 mm Hg; group 2: 154.2 +/- 13.6/104.9 +/- 9.3 versus 129.6 +/- 10.2/83.7 +/- 9.1 mm Hg; group 3: 158.3 +/- 27.1/104.1 +/- 8.0 versus 129.1 +/- 6.6/87.5 +/- 6.1 mm Hg). The doses of atenolol were 62.5 +/- 23.0 mg/day in group 1, 70.0 +/- 30.0 mg/day in group 2, and 100.0 +/- 41.0 mg/day in group 3. There was no fetal mortality. No significant difference occurred in newborn body weights. Four babies from group 2 mothers had an Apgar score of less than 7 at 1 minute, but only one remained abnormal after 5 minutes. In the same group, three cases of respiratory distress were observed.(ABSTRACT TRUNCATED AT 250 WORDS)
G Fabregues; L Alvarez; P Varas Juri; S Drisaldi; C Cerrato; C Moschettoni; D Pituelo; H P Baglivo; R J Esper
Related Documents :
19406886 - Long term monitoring in patients receiving treatment to lower blood pressure: analysis ...
3891616 - Chronic dietary tyrosine supplements do not affect mild essential hypertension.
19948706 - The physician at a distance: the use of videoconferencing in the treatment of patients ...
24250976 - Administration of remifentanil in establishing a more stable post-anesthesia cardiovasc...
8179846 - Antihypertensive effects of aerobic exercise. a brief meta-analytic review of randomize...
22254896 - New insight into arrhythmia onset using hrv and bpv analysis.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Hypertension     Volume:  19     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  1992 Feb 
Date Detail:
Created Date:  1992-03-06     Completed Date:  1992-03-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  II129-31     Citation Subset:  IM    
Cardiology Division, Policlinica Bancaria, Buenos Aires, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atenolol / therapeutic use*
Hypertension / drug therapy*
Pregnancy Complications, Cardiovascular / drug therapy*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Actions of cromakalim in isolated human saphenous vein.
Next Document:  Cadralazine for the treatment of preeclampsia. An open, noncomparative, dose-finding pilot study.